TEIJIN : Febuxostat (FEBURIC(R)) Launches in Korea(Teijin Pharma) - 4-traders (press release)

TEIJIN : Febuxostat (FEBURIC(R)) Launches in Korea(Teijin Pharma) 4-traders (press release) In June 2009, SK Chemicals received approval from the Korea Food and Drug Administration to market the drug in the country for treatment of chronic hyperuricemia in patients with gout. Febuxostat already is marketed by licensees, Takeda Pharmaceuticals ... and more »

A troubled teen and the complex world of managed care - ModernMedicine

ModernMedicine

A troubled teen and the complex world of managed care ModernMedicine I was able to help re-establish Bobby's diabetes care and secured a home NBUVB box — the last sanctioned union perk. A few months later, the family's insurance was cancelled. Bobby's access to Xolair was abruptly severed. Four months later, all hell ...

NEWS BITES - Times Online - Auckland

NEWS BITES Times Online - Auckland A MEDICAL group is calling on district health boards (DHBs) across the country to sign up for a research project on gout. The Pharmacy Guild is seeking partners to reach out to people with gout following the success of an earlier programme in Counties ...

Why Medicaid Cuts Harm Us All - Huffington Post (blog)

Why Medicaid Cuts Harm Us All Huffington Post (blog) The records Randy received were flimsy, but he noticed that the patient was on allopurinol, a treatment for gout. As any first year medical student can tell you, gout is a very painful form of arthritis that is caused by high uric acid levels in the ...